HHS is a neuroscience company dedicated to combatting acquired hearing loss, which is an avoidable health issue now affecting the quality of life and livelihood of 1.2 billion people globally. We think differently about the hearing loss problem. We’re in the wellness business. We make products to maintain hearing health. Everything we do is scientifically validated. Safe. User friendly. For everyone.
HHS developed a unique, multi-patented preventive care therapeutic for hearing preservation known as ACEMg (say “ace mag”). ACEMg addresses the root cause of hearing loss by eliminating excess inner ear free radicals and maintaining normal inner ear blood flow. ACEMg Clinical Care products are available to physicians treating infants and children with genetic, viral and antibiotic-induced hearing loss. ACEMg is covered by 8 patents. ACEMg branded Soundbites for consumers.
Our mission is to bring Dr. Miller’s discoveries to the world market. Our vision is to solve the hearing loss problem for everyone.
Our company builds on a foundation of three decades of basic and translational auditory neuroscience research started in 1985. Ten years of basic science resulted in discoveries about free radical-induced inner ear pathologies that changed the basic scientific concept of acquired hearing loss from biomechanical to biochemical. Ten more years of research discovered a micronutrient formula that eliminates the root cause of the biochemical disorder. Following a further decade of translational research and product development, the company is now engaged in the process of bringing the solution to the world market, along with continuing preclinical, clinical and epidemiological investigations.
Clinical Trial Starts
(National Institutes of Health)
ACEMg discovery journal article published in Free Radical Biology and Medicine
Large scale launch into the US market
Meet the Team
Katherine van Eck Armstrong
Nina van Wijk
Social Media Manager